Acurx Pharmaceuticals's total assets for Q2 2024 were $6.58M, a decrease of -27.76% from the previous quarter. ACXP total liabilities were $3.15M for the fiscal quarter, a 1.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.